Other
Buck Institute for Research on Aging
Total Trials
8
Recruiting
5
Active
5
Completed
2
Success Rate
100.0%+13% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
Failure Rate
0.0%
0 terminated/withdrawn out of 8 trials
Success Rate
100.0%
+13.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed trials have results
Key Signals
5 recruiting
Enrollment Performance
Analytics
N/A
4(80.0%)
Early Phase 1
1(20.0%)
5Total
N/A(4)
Early Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (8)
Showing 8 of 8 trials
NCT06645847Not ApplicableRecruiting
Targeting Aging With a Ketone Ester for Function in Frailty
Role: lead
NCT07192861Enrolling By Invitation
BETA - Pilot Study
Role: collaborator
NCT06813261Not ApplicableRecruiting
GLYLO Supplement Pilot Trial on Glycation and Aging in Postmenopausal Women
Role: lead
NCT07107386Recruiting
Temporal Investigation of Multimodal Elements
Role: lead
NCT06242535Early Phase 1Completed
Pilot Study of GLY-LOW Supplementation in Postmenopausal Women With Obesity
Role: collaborator
NCT05924295Not ApplicableRecruiting
Variations in Ketone Metabolism
Role: collaborator
NCT06540287Recruiting
Molecular Optimization Via Exercise (MOVE)
Role: lead
NCT05585762Not ApplicableCompleted
Buck Institute Ketone Ester RCT
Role: lead
All 8 trials loaded